BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2021 8:21:53 AM | Browse: 411 | Download: 832
 |
Received |
|
2021-02-28 12:26 |
|
Peer-Review Started |
|
2021-02-28 12:28 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-07 00:18 |
|
Revised |
|
2021-06-10 04:39 |
|
Second Decision |
|
2021-07-12 03:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-12 06:12 |
|
Articles in Press |
|
2021-07-12 06:12 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-11-30 12:36 |
|
Typeset the Manuscript |
|
2021-12-26 15:31 |
|
Publish the Manuscript Online |
|
2021-12-30 08:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
HER2 turns to positive after neoadjuvant chemotherapy in breast cancer: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Luo Wang, Qi Jiang, Meng-Ye He and Peng Shen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Peng Shen, MD, Doctor, Doctor, Department of Medical Oncology, The first Affliated Hospital,College of Medicine,Zhejiang University, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. shenp@zju.edu.cn |
| Key Words |
Carcinoma; Ductal; Breast; Neoadjuvant therapy; Biomarkers, Tumor; Case report |
| Core Tip |
Precise molecular subtype of breast cancer is helpful to make individualized strategies for systemic treatment, we thus pay more attention to the changes of tumor biomarkers before and after surgery. The conversion probability is fairly low, especially in HER2 status, however, it directly affects the formulation of adjuvant treatment. A more important fact is that anti-HER2 therapy has led to a landmark change in patients with HER2 positive breast cancer. |
| Publish Date |
2021-12-30 08:21 |
| Citation |
Wang L, Jiang Q, He MY, Shen P. HER2 turns to positive after neoadjuvant chemotherapy in breast cancer: A case report and review of literature. World J Clin Cases 2022; 10(1): 260-267 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i1/260.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i1.260 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
